Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between air pollution and incident cardiovascular diseases among a population with cardiovascular-kidney-metabolic syndrome stages 0-3: the first evidence from the China Health and Retirement Longitudinal Study.

Frontiers in endocrinology·2026
Same author

Longitudinal lipidomic markers of cardiac aging and risk of coronary heart disease in American Indians: the Strong Heart Family Study.

GeroScience·2026
Same author

Lysosome-dependent cell death in hepatocellular carcinoma: unlocking the therapeutic potential of natural products.

Frontiers in pharmacology·2026
Same author

Frequent exposure to biologics is associated with small intestinal bacterial overgrowth in patients with Crohn's disease: a retrospective case-control study.

PeerJ·2026
Same author

Oxford Nanopore Technologies Sequencing and Targeted Amino Acid Metabolomics Reveal Spatially Segregated Microbial Hijacking and Metabolic Collapse During <i>Trichoderma</i> Infection of Golden Ear Mushroom.

Foods (Basel, Switzerland)·2026
Same author

Intratumor <i>Lactobacillus</i> drives ferroptosis resistance via D-lactate-STAT3 K631 lactylation in esophageal squamous cell carcinoma.

Gut microbes·2026

Related Experiment Video

Updated: May 10, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Risk Stratification of Suspected Clinically Localized Prostate Cancer Using Multi-Indicator Functional

Liuying Li1, Yijing Xu1, Mingjing Chen1

  • 1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, China.

Archivos Espanoles De Urologia
|May 9, 2026
PubMed
Summary

A new nomogram accurately predicts significant prostate cancer in men with borderline PSA levels. This tool integrates biomarkers and MRI to improve risk stratification and guide treatment decisions.

Keywords:
PCA3 scorenomogramsprostate cancerprostate health indexrisk stratification

More Related Videos

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

Related Experiment Videos

Last Updated: May 10, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

Area of Science:

  • Urology
  • Oncology
  • Medical Imaging

Background:

  • Accurate risk stratification is vital for localized prostate cancer, especially with total prostate-specific antigen (tPSA) in the 4-10 ng/mL grey zone.
  • Distinguishing clinically insignificant prostate cancer from significant disease is challenging.

Purpose of the Study:

  • Develop and validate a predictive model for prostate cancer risk stratification.
  • Integrate multi-dimensional indicators for improved diagnostic accuracy.

Main Methods:

  • Retrospective cohort study of 242 patients with suspected localized prostate cancer.
  • Analysis of biomarkers: free prostate-specific antigen/tPSA ratio (%fPSA), Prostate Health Index (PHI), Prostate Cancer Antigen 3 (PCA3) score.
  • Inclusion of multiparametric magnetic resonance imaging (mp-MRI) parameters, including PI-RADS scores.

Main Results:

  • High-risk group showed lower %fPSA and prostate volume, higher PHI, PCA3, and PI-RADS findings (p < 0.05).
  • Multivariate analysis identified %fPSA, PHI, PCA3, prostate volume, PI-RADS score ≥ 4, and index lesion diameter as independent predictors.
  • Developed nomogram achieved high discrimination (AUC = 0.885 development, 0.863 validation).

Conclusions:

  • A novel nomogram effectively integrates biomarkers and MRI for personalized prostate cancer risk stratification.
  • This multi-modal approach offers superior accuracy compared to single-modality methods.
  • The tool aids in distinguishing significant from insignificant prostate cancer, guiding clinical management.